What type of study is this?

This is a Animal Study study (also classified as: Observational).

August 22, 2025Open Access

Liposomal Bupivacaine: A Delay Rather Than Elimination of Rebound Pain in Mouse Postoperative Model

View Full Paper

Ask AI

Bookmark

Liposomal bupivacaine prolonged thermal analgesia for 24 hours and mechanical analgesia for 36 hours in mice, indicating its efficacy.
Rebound pain was delayed but not eliminated, with transient thermal hyperalgesia observed at 48 hours post-surgery, suggesting neuroinflammation involvement.
Assessments were performed using advanced measures like von Frey and Hargreaves, providing robust pain management insights in clients.
A well-validated mouse model for peripheral nerve block was successfully developed, supporting future research on analgesic strategies.

No takes yet. Share an insight, caveat, or question.

Analysis shows liposomal bupivacaine reduces rebound pain in postoperative mice, highlighting its analgesic potential.

Wu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark